HIMS
Hims & Hers Health, Inc. is an American telehealth company that sells prescription and over-the-counter drugs online, as well as personal care products. The company is best known for selling generic treatments for erectile dysfunction and hair loss.
Hims & Hers Health, Inc. (HIMS) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Revisions (D).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | C+ (2.6) | B- (3.0) | C+ (2.7) | C+ (2.6) | D (1.3) | C (2.4) |
| 2026-11-09 | C+ (2.8) | B+ (3.6) | C+ (2.7) | C (2.5) | D (1.3) | C+ (2.6) |
| 2026-11-02 | C+ (2.8) | B+ (3.6) | C+ (2.7) | C+ (2.7) | D (1.4) | C+ (2.6) |
| 2026-10-30 | C+ (2.8) | B+ (3.6) | C+ (2.7) | C (2.3) | D (1.4) | C+ (2.6) |
| 2026-10-26 | C+ (2.8) | B+ (3.6) | C+ (2.7) | C (2.3) | D (1.4) | C+ (2.6) |